Berenberg Lifts Lilly to Buy With a $1,400 Target
Eli Lilly and Co. NYSE:LLY rose 1.27% premarket after Berenberg upgraded it to Buy from Hold and lifted its price target to $1,400 from $1,220, implying roughly 22% upside from current levels. The firm's 2026 return on research investment work found Lilly delivering best-in-class returns, and it ex…